Cover Image
市場調查報告書

全球精密醫療市場

Global Market Study on Precision Medicine: Drug Discovery Technology Segment Estimated to Witness 0.1% Decline in Market Share Between 2016 and 2024

出版商 Persistence Market Research 商品編碼 457237
出版日期 內容資訊 英文 169 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球精密醫療市場 Global Market Study on Precision Medicine: Drug Discovery Technology Segment Estimated to Witness 0.1% Decline in Market Share Between 2016 and 2024
出版日期: 2016年12月09日 內容資訊: 英文 169 Pages
簡介

本報告提供今後的全球精密醫療市場相關調查分析,提供市場趨勢,市場動態,市場現況與展望等相關考察,再全面性分析、彙整各技術,用途,地區別市場分析,及競爭情形等資訊。

第1章 摘要整理

第2章 市場簡介

  • 市場定義
  • 市場分類

第3章 全球精密醫療市場分析方案

  • 市場規模與預測
  • 市場概要

第4章 市場動態

  • 宏觀經濟學的因素
  • 促進成長要素
  • 阻礙成長要素
  • 市場機會
  • 預測因素
  • 技術的進步
  • 用途的擴大
  • 研究的津貼

第5章 全球精密醫療市場分析與預測:各技術

  • 簡介
  • basis point·佔有率(BPS)分析:各技術
  • 上年度比成長預測:各技術
  • 市場規模預測:各技術
  • 主要趨勢
  • 市場魅力分析:各技術

第6章 全球精密醫療市場分析與預測:各用途

  • 簡介
  • basis point·佔有率(BPS)分析:各用途
  • 上年度比成長預測:各用途
  • 市場規模預測:各用途
  • 主要趨勢
  • 市場魅力分析:各用途

第7章 全球精密醫療市場分析與預測:各地區

  • basis point·佔有率(BPS)分析:各地區
  • 上年度比成長預測:各地區
  • 市場規模預測:各地區
  • 市場魅力分析:各地區

第8章 北美的精密醫療市場分析與預測

  • 簡介
  • 市場規模預測:各技術
  • 市場規模預測:各用途
  • 市場規模預測:各國
  • 市場魅力分析
  • 主要趨勢
  • 促進要素與抑制因素:影響分析

第9章 南美的精密醫療市場分析與預測

  • 簡介
  • 市場規模預測:各技術
  • 市場規模預測:各用途
  • 市場規模預測:各國
  • 市場魅力分析
  • 主要趨勢
  • 促進要素與抑制因素:影響分析

第10章 歐洲的精密醫療市場分析與預測

  • 簡介
  • 市場規模預測:各技術
  • 市場規模預測:各用途
  • 市場規模預測:各國
  • 市場魅力分析
  • 主要趨勢
  • 促進要素與抑制因素:影響分析

第11章 亞太地區的精密醫療市場分析與預測

  • 簡介
  • 市場規模預測:各技術
  • 市場規模預測:各用途
  • 市場規模預測:各國
  • 市場魅力分析
  • 主要趨勢
  • 促進要素與抑制因素:影響分析

第12章 中東/非洲的精密醫療市場分析與預測

  • 簡介
  • 市場規模預測:各技術
  • 市場規模預測:各用途
  • 市場規模預測:各國
  • 市場魅力分析
  • 主要趨勢
  • 促進要素與抑制因素:影響分析

第13章 競爭情形

  • 競爭情形
  • 市場佔有率分析:各企業
  • 企業簡介

第14章 假設和簡稱

第15章 調查方法

圖表

目錄

Precision medicine is an emerging approach to preventive health and for the treatment of disease. The approach allows doctors and physicians to study the individual response to a therapy. The approach studies the individual profile at a genetic level along with their lifestyle and environment. In January 2015, Precision Medicine Initiative (PMI) was announced to extend precision medicine to all diseases with more than one million volunteers. All of The Unified Shared Services Management, a data-driven enterprise supported research at the intersection of environment, lifestyle and genetics to treat disease and prolong health. Targeted cancer therapy, use of combination therapies and knowledge of drug resistance were some of the short term goals. While the long-term goal was to create a cohort of 1 million American volunteers to share genetic data, lifestyle information, biological samples which would be linked to the electronic health record. This would advance pharmacogenomics and lay a scientific foundation for precision medicine for many diseases.

Global Precision Medicine Market Value and Forecast

The global precision medicine market, estimated to be worth around US$ 56 Bn by 2016 end, is expected to expand at an approximate CAGR of 14% over the forecast period of 2016-2024. North America accounted for largest market share and the net average net worth of the market was close to US$ 19 Bn in 2015 and is expected to expand at a CAGR of more than 13.5 % over the forecast period.

Global Precision Medicine Market Dynamics

Factors such as the increasing approval of drug along with its companion diagnostic assay, cost- effective profiling of DNA, increasing incidence rate of cancer and rise of data-driven healthcare are some of the reasons leading to the growth of the precision medicine market. Moreover, the increasing use of "multi-omics" in research along with the penetration of high-throughput sequencing platforms is also shaping up the precision medicine scenario. The number of targeted molecules in pipeline for a specific application has been exponentially growing specifically in oncology.

The current escalating price of drug discovery along with increasing regulatory requirements has increased the demand for an individualized product. The development of companion diagnostics appears to offer a set of tools as well as relevant clinical and biological information to address various pharmaceutical companies. Industry players are now patenting a molecule along with its companion diagnostics to achieve a competitive edge, profit margin and more usage. With the available companion diagnostics, both patient and physicians are assured of the therapy effectiveness.

Global Precision Medicine Market Segmentation Forecast

Based on application, the market has been segmented into multiple layers. Oncology, Immunology, Neurology, Cardiology, Infectious disease and others are some of the crucial streams of application segment. Oncology segment accounts for a significant share in terms of revenue of the total precision medicine market; however, immunology segment is anticipated to witness an impressive CAGR over the forecast period.

precsion medicine market

Global Precision Medicine Market Forecast by Region

Geographically, North America is leading the precision medicine market. The massive investment in the field of precision medicine in US will trigger the growth of the market within the assessment period. Though the funding is for oncology targeted therapy, the research would gradually expand to other applications. North America is at the forefront as far as the acceptance and utilization of precision medicine is concerned. As economically developing regions such as Asia-Pacific are still behind the developed countries, this region has huge potential for market growth, and this region will showcase significant hike by the end of the forecast period.

Key Players Operating in the Global Precision Medicine Market

Some of the players in the global precision medicine market are, F Hoffmann-La Roche AG, Illumina, Inc., Thermo Fisher Scientific Inc., QIAGEN, Quest Diagnostics, Laboratory Corporation of America Holdings, Novartis AG, AstraZeneca, Bristol-Myers Squibb and Eli Lilly And Company. The companies are trying to increase their product pipeline by filing new molecule application or by extending the application of the existing molecule.

Other strategies such as merger and acquisitions, industry academia collaboration to bring in more commercialized molecule or sequencing techniques will also impact the present market trends. The report also identifies company-specific strategies related to product development, market consolidation initiatives and analysis of their specific strengths, weaknesses, opportunities and threats.

Table of Contents

1. Executive Summary

2. Market Introduction

  • 2.1. Market Definition
  • 2.2. Market Taxonomy

3. Global Precision Medicine Market Analysis Scenario

  • 3.1. Market Size (US$ Mn) and Forecast
    • 3.1.1. Market Size and Y-o-Y Growth
    • 3.1.2. Absolute $ Opportunity
  • 3.2. Market Overview

4. Market Dynamics

  • 4.1. Macro-economic Factors
  • 4.2. Drivers
    • 4.2.1. Supply Side
    • 4.2.2. Demand Side
  • 4.3. Restraints
  • 4.4. Opportunity
  • 4.5. Forecast Factors - Relevance and Impact
  • 4.6. Technology Advancement
  • 4.7. Application Expansion
  • 4.8. Research Funding

5. Global Precision Medicine Market Analysis and Forecasts, By Technology

  • 5.1. Introduction
  • 5.2. Basis Point Share (BPS) Analysis By Technology Type
  • 5.3. Y-o-Y Growth Projections By Technology Type
  • 5.4. Market value Forecast By Technology, 2016-2024
    • 5.4.1. NGS
    • 5.4.2. Drug Discovery Technologies
    • 5.4.3. Bioinformatics
  • 5.5. Prominent Trends
  • 5.6. Market Attractiveness By Technology

6. Global Precision Medicine Market Analysis and Forecasts, By Application

  • 6.1. Introduction
  • 6.2. Basis Point Share (BPS) Analysis By Application
  • 6.3. Y-o-Y Growth Projections By Application
  • 6.4. Market value Forecast By Application, 2016-2024
    • 6.4.1. Oncology
    • 6.4.2. Immunology
    • 6.4.3. Neurology
    • 6.4.4. Cardiology
    • 6.4.5. Infectious Diseases
    • 6.4.6. Others
  • 6.5. Prominent Trends
  • 6.6. Market Attractiveness By Application

7. Global Precision Medicine Market Analysis and Forecasts, By Region

  • 7.1. Basis Point Share (BPS) Analysis By Region
  • 7.2. Y-o-Y Growth Projections By Region
  • 7.3. Market value Forecast By Region
    • 7.3.1. North America
    • 7.3.2. Latin America
    • 7.3.3. Europe
    • 7.3.4. Asia Pacific
    • 7.3.5. Middle East and Africa
  • 7.4. Market Attractiveness By Region

8. North America Precision Medicine Market Analysis and Forecast

  • 8.1. Introduction
    • 8.1.1. Basis Point Share (BPS) Analysis By Country
    • 8.1.2. Y-o-Y Growth Projections By Country
    • 8.1.3. Key Regulations
  • 8.2. Market value Forecast By Technology, 2016-2024
    • 8.2.1. NGS
    • 8.2.2. Drug Discovery Technologies
    • 8.2.3. Bioinformatics
  • 8.3. Market value Forecast By Application, 2016-2024
    • 8.3.1. Oncology
    • 8.3.2. Immunology
    • 8.3.3. Neurology
    • 8.3.4. Cardiology
    • 8.3.5. Infectious Diseases
    • 8.3.6. Others
  • 8.4. Market value Forecast By Country, 2016-2024
    • 8.4.1. U.S.
    • 8.4.2. Canada
  • 8.5. Market Attractiveness Analysis
    • 8.5.1. By Technology
    • 8.5.2. By Application
    • 8.5.3. By Country
  • 8.6. Prominent Trends
  • 8.7. Drivers and Restraints: Impact Analysis

9. Latin America Precision Medicine Market Analysis and Forecast

  • 9.1. Introduction
    • 9.1.1. Basis Point Share (BPS) Analysis By Country
    • 9.1.2. Y-o-Y Growth Projections By Country
    • 9.1.3. Key Regulations
  • 9.2. Market value Forecast By Technology, 2016-2024
    • 9.2.1. NGS
    • 9.2.2. Drug Discovery Technologies
    • 9.2.3. Bioinformatics
  • 9.3. Market value Forecast By Application, 2016-2024
    • 9.3.1. Oncology
    • 9.3.2. Immunology
    • 9.3.3. Neurology
    • 9.3.4. Cardiology
    • 9.3.5. Infectious Diseases
    • 9.3.6. Others
  • 9.4. Market value Forecast By Country, 2016-2024
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America
  • 9.5. Market Attractiveness Analysis
    • 9.5.1. By Technology
    • 9.5.2. By Application
    • 9.5.3. By Country
  • 9.6. Prominent Trends
  • 9.7. Drivers and Restraints: Impact Analysis

10. Europe Precision Medicine Market Analysis and Forecast

  • 10.1.Introduction
    • 10.1.1. Basis Point Share (BPS) Analysis By Country
    • 10.1.2. Y-o-Y Growth Projections By Country
    • 10.1.3. Key Regulations
  • 10.2.Market value Forecast By Technology, 2016-2024
    • 10.2.1. NGS
    • 10.2.2. Drug Discovery Technologies
    • 10.2.3. Bioinformatics
  • 10.3.Market value Forecast By Application, 2016-2024
    • 10.3.1. Oncology
    • 10.3.2. Immunology
    • 10.3.3. Neurology
    • 10.3.4. Cardiology
    • 10.3.5. Infectious Diseases
    • 10.3.6. Others
  • 10.4.Market value Forecast By Country, 2016-2024
    • 10.4.1. U.K.
    • 10.4.2. France
    • 10.4.3. Germany
    • 10.4.4. Italy
    • 10.4.5. Spain
    • 10.4.6. Rest of Europe
  • 10.5.Market Attractiveness Analysis
    • 10.5.1. By Technology
    • 10.5.2. By Application
    • 10.5.3. By Country
  • 10.6. Prominent Trends
  • 10.7. Drivers and Restraints: Impact Analysis

11. Asia Pacific Precision Medicine Market Analysis and Forecast

  • 11.1.Introduction
    • 11.1.1. Basis Point Share (BPS) Analysis By Country
    • 11.1.2. Y-o-Y Growth Projections By Country
    • 11.1.3. Key Regulations
  • 11.2.Market value Forecast By Technology, 2016-2024
    • 11.2.1. NGS
    • 11.2.2. Drug Discovery Technologies
    • 11.2.3. Bioinformatics
  • 11.3.Market value Forecast By Application, 2016-2024
    • 11.3.1. Oncology
    • 11.3.2. Immunology
    • 11.3.3. Neurology
    • 11.3.4. Cardiology
    • 11.3.5. Infectious Diseases
    • 11.3.6. Others
  • 11.4.Market value Forecast By Country, 2016-2024
    • 11.4.1. Japan
    • 11.4.2. China
    • 11.4.3. India
    • 11.4.4. Australia
    • 11.4.5. New Zealand
    • 11.4.6. Rest of Asia Pacific
  • 11.5.Market Attractiveness Analysis
    • 11.5.1. By Technology
    • 11.5.2. By Application
    • 11.5.3. By Country
  • 11.6. Prominent Trends
  • 11.7. Drivers and Restraints: Impact Analysis

12. Middle East and Africa Precision Medicine Market Analysis and Forecast

  • 12.1.Introduction
    • 12.1.1. Basis Point Share (BPS) Analysis By Country
    • 12.1.2. Y-o-Y Growth Projections By Country
    • 12.1.3. Key Regulations
  • 12.2.Market value Forecast By Technology, 2016-2024
    • 12.2.1. NGS
    • 12.2.2. Drug Discovery Technologies
    • 12.2.3. Bioinformatics
  • 12.3.Market value Forecast By Application, 2016-2024
    • 12.3.1. Oncology
    • 12.3.2. Immunology
    • 12.3.3. Neurology
    • 12.3.4. Cardiology
    • 12.3.5. Infectious Diseases
    • 12.3.6. Others
  • 12.4.Market value Forecast By Country, 2016-2024
    • 12.4.1. GCC Countries
    • 12.4.2. South Africa
    • 12.4.3. Saudi Arabia
    • 12.4.4. Rest of MEA
  • 12.5.Market Attractiveness Analysis
    • 12.5.1. By Technology
    • 12.5.2. By Application
    • 12.5.3. By Country
  • 12.6. Prominent Trends
  • 12.7. Drivers and Restraints: Impact Analysis

13. Competition Landscape

  • 13.1. Competition Dashboard
  • 13.2. Market Share Analysis By Company (2015)
  • 13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 13.3.1. F. Hoffmann-La Roche AG
    • 13.3.2. Illumina, Inc.
    • 13.3.3. Thermo Fisher Scientific Inc.
    • 13.3.4. QIAGEN
    • 13.3.5. Quest Diagnostics
    • 13.3.6. Laboratory Corporation of America Holdings
    • 13.3.7. Novartis AG
    • 13.3.8. AstraZeneca
    • 13.3.9. Bristol-Myers Squibb
    • 13.3.10. Eli Lilly And Company

14. Assumptions and Acronyms Used

15. Research Methodology

List of Tables

  • Table 01: Global Precision Medicine Market Size (US$ Mn) Forecast: by Technology, 2016-2024
  • Table 02: Global Precision Medicine Market Size (US$ Mn) Forecast: by Application, 2016-2024
  • Table 03: Global Precision Medicine Market Size (US$ Mn) Forecast: by Region, 2016-2024
  • Table 04: North America Precision Medicine Market Size (US$ Mn) Forecast: by Technology, 2016-2024
  • Table 05: North America Precision Medicine Market Size (US$ Mn) Forecast: by Application, 2016-2024
  • Table 06: North America Precision Medicine Market Size (US$ Mn) Forecast: by Country, 2016-2024
  • Table 07: Europe Precision Medicine Market Size (US$ Mn) Forecast: by Technology, 2016-2024
  • Table 08: Europe Precision Medicine Market Size (US$ Mn) Forecast: by Application, 2016-2024
  • Table 09: Europe Precision Medicine Market Size (US$ Mn) Forecast: by Country, 2016-2024
  • Table 10: Asia Pacific Precision Medicine Market Size (US$ Mn) Forecast: by Technology, 2016-2024
  • Table 11: Asia Pacific Precision Medicine Market Size (US$ Mn) Forecast: by Application, 2016-2024
  • Table 12: Asia Pacific Precision Medicine Market Size (US$ Mn) Forecast: by Country, 2016-2024
  • Table 13: Latin America Precision Medicine Market Size (US$ Mn) Forecast: by Technology, 2016-2024
  • Table 14: Latin America Precision Medicine Market Size (US$ Mn) Forecast: by Application, 2016-2024
  • Table 15: Latin America Precision Medicine Market Size (US$ Mn): by Country, 2016-2024
  • Table 16: Middle East & Africa Precision Medicine Market Size (US$ Mn) Forecast: by Technology, 2016-2024
  • Table 17: Middle East & Africa Precision Medicine Market Value (US$ Mn) Forecast: by Application, 2016-2024
  • Table 18: Middle East & Africa Precision Medicine Market Size (US$ Mn) Forecast: by Country, 2016-2024

List of Figures

  • Figure 01: Global Precision Medicine (US$ Mn) Forecast, 2016-2024
  • Figure 02: Global Precision Medicine Market, Absolute $ Opportunity (US$ Mn), 2016-2024
  • Figure 03: Global Precision Medicine Market Value Share Analysis: by Technology, 2016 and 2024
  • Figure 04: Global NGS Market Value (US$ Mn) and Y-o-Y Growth (%), 2016-2024
  • Figure 05: Global Drug Discovery Technologies Market Value (US$ Mn) and Y-o-Y Growth (%), 2016-2024
  • Figure 06: Global Bioinformatics Market Value (US$ Mn) and Y-o-Y Growth (%), 2016-2024
  • Figure 07: Global Precision Medicine Market Attractiveness Analysis: by Technology
  • Figure 08: Global Precision Medicine Market Value Share Analysis: by Application, 2016 and 2024
  • Figure 09: Global Oncology Market Value (US$ Mn) and Y-o-Y Growth (%), 2016-2024
  • Figure 10: Global Immunology Market Value (US$ Mn) and Y-o-Y Growth (%), 2016-2024
  • Figure 11: Global Neurology Market Value (US$ Mn) and Y-o-Y Growth (%), 2016-2024
  • Figure 12: Global Cardiology Market Value (US$ Mn) and Y-o-Y Growth (%), 2016-2024
  • Figure 13: Global Infectious Disease Market Value (US$ Mn) and Y-o-Y Growth (%), 2016-2024
  • Figure 14: Global Others Market Value (US$ Mn) and Y-o-Y Growth (%), 2016-2024
  • Figure 15: Global Precision Medicine Market Attractiveness Analysis: by Application
  • Figure 16: Global Precision Medicine Market Value Share Analysis, by Region, 2016 and 2024
  • Figure 17: Global Precision Medicine Market Attractiveness Analysis, by Region
  • Figure 18: North America Precision Medicine Market Size (US$ Mn) Forecast, 2016-2024
  • Figure 19: North America Precision Medicine Market Size and Y-o-Y Growth Projections, 2016-2024
  • Figure 20: North America Precision Medicine Market Attractiveness Analysis, by Country
  • Figure 21: North America Precision Medicine Market Value Share Analysis, by Technology, 2016 and 2024
  • Figure 22: North America Precision Medicine Market Value Share Analysis: by Application, 2016 and 2024
  • Figure 23: North America Precision Medicine Market Value Share Analysis: by Country, 2016 and 2024
  • Figure 24: The U.S. Precision Medicine Market Size (US$ Mn) Forecast, 2016-2024
  • Figure 25: The U.S. Precision Medicine Market, Absolute $ Opportunity (US$ Mn), 2016-2024
  • Figure 26: Canada Precision Medicine Market Size (US$ Mn) Forecast, 2016-2024
  • Figure 27: Canada Precision Medicine Market, Absolute $ Opportunity (US$ Mn), 2016-2024
  • Figure 28: North America Precision Medicine Market Attractiveness Analysis: by Technology, 2016-2024
  • Figure 29: North America Precision Medicine Market Attractiveness Analysis: by Application, 2016-2024
  • Figure 30: Europe Precision Medicine Market Size (US$ Mn) Forecast, 2016-2024
  • Figure 31: Europe Precision medicine Y-o-Y Growth Projections, 2016-2024
  • Figure 32: Europe Market Attractiveness Analysis: by Country
  • Figure 33: Europe Precision Medicine Market Value Share Analysis: by Technology, 2016 and 2024
  • Figure 34: Europe Precision Medicine Market Value Share Analysis: by Application, 2016 and 2024
  • Figure 35: Europe Precision Medicine Market Value Share Analysis: by Country, 2016 and 2024
  • Figure 36: Germany Precision Medicine Market Size (US$ Mn) Forecast, 2016-2024
  • Figure 37: Germany Precision Medicine Market, Absolute $ Opportunity (US$ Mn), 2016-2024
  • Figure 38: The U.K. Precision Medicine Market Size (US$ Mn) Forecast, 2016-2024
  • Figure 39: The U.K. Precision Medicine Market, Absolute $ Opportunity (US$ Mn), 2016-2024
  • Figure 40: France Precision Medicine Market Size (US$ Mn) Forecast, 2016-2024
  • Figure 41: France Precision Medicine Market, Absolute $ Opportunity (US$ Mn), 2016-2024
  • Figure 42: Italy Precision Medicine Market Size (US$ Mn) Forecast, 2016-2024
  • Figure 43: Italy Precision Medicine Market, Absolute $ Opportunity (US$ Mn), 2016-2024
  • Figure 44: Spain Precision Medicine Market Size (US$ Mn) Forecast, 2016-2024
  • Figure 45: Spain Precision Medicine Market Absolute $ Opportunity (US$ Mn), 2016-2024
  • Figure 46: Rest of Europe Precision Medicine Market Size (US$ Mn) Forecast, 2016-2024
  • Figure 47: Rest of Europe Precision Medicine Market, Absolute $ Opportunity (US$ Mn), 2016-2024
  • Figure 48: Europe Precision Medicine Market Attractiveness Analysis, by Technology Type, 2016-2024
  • Figure 49: Europe Precision Medicine Market Attractiveness Analysis, by Application, 2016-2024
  • Figure 50: Asia Pacific Precision Medicine Market Size (US$ Mn) Forecast, 2016-2024
  • Figure 51: Asia Pacific Precision Medicine Market Size and Y-o-Y Growth Projections, 2016-2024
  • Figure 52: Asia Pacific Precision Medicine Market Attractiveness Analysis: by Country, 2016-2024
  • Figure 53: Asia Pacific Precision Medicine Market Value Share Analysis: by Technology, 2016 and 2024
  • Figure 54: Asia Pacific Precision Medicine Market Value Share Analysis: by Application, 2016 and 2024
  • Figure 55: China Precision Medicine Market, Absolute $ Opportunity (US$ Mn), 2016-2024
  • Figure 56: Japan Precision Medicine Market Size (US$ Mn) Forecast, 2016-2024
  • Figure 57: Japan Precision Medicine Market, Absolute $ Opportunity (US$ Mn), 2016-2024
  • Figure 58: India Precision Medicine Market Size (US$ Mn) Forecast, 2016-2024
  • Figure 59: India Precision Medicine Market, Absolute $ Opportunity (US$ Mn), 2016-2024
  • Figure 60: Australia Precision Medicine Market Size (US$ Mn) Forecast, 2016-2024
  • Figure 61: Australia Precision Medicine Market, Absolute $ Opportunity (US$ Mn), 2016-2024
  • Figure 62: New Zealand Precision Medicine Market Size (US$ Mn) Forecast, 2016-2024
  • Figure 63: New Zealand Precision Medicine Market, Absolute $ Opportunity (US$ Mn), 2016-2024
  • Figure 64: Rest of APAC Precision Medicine Market Size (US$ Mn) Forecast, 2016-2024
  • Figure 65: Rest of APAC Precision Medicine Market, Absolute $ Opportunity (US$ Mn), 2016-2024
  • Figure 66: Asia Pacific Precision Medicine Market Attractiveness Analysis: by Technology, 2016-2024
  • Figure 67: Asia Pacific Precision Medicine Market Attractiveness Analysis: by Application, 2016-2024
  • Figure 68: Latin America Precision Medicine Market Size (US$ Mn) Forecast, 2016-2024
  • Figure 69: Latin America Precision Medicine Market Size and Y-o-Y Growth Projections, 2016-2024
  • Figure 70: Latin America Market Attractiveness Analysis, by Country
  • Figure 71: Latin America Precision Medicine Market Value Share Analysis: by Technology, 2016 and 2024
  • Figure 72: Latin America Precision Medicine Market Value Share Analysis: by Application, 2016 and 2024
  • Figure 73: Latin America Market Value Share Analysis: by Country, 2016 and 2024
  • Figure 74: Brazil Precision Medicine Market Size (US$ Mn) Forecast, 2016-2024
  • Figure 75: Brazil Precision Medicine Market, Absolute $ Opportunity (US$ Mn), 2016-2024
  • Figure 76: Mexico Precision Medicine Market Size (US$ Mn) Forecast, 2016-2024
  • Figure 77: Mexico Precision Medicine Market, Absolute $ Opportunity (US$ Mn), 2016-2024
  • Figure 78: Rest of LATAM Precision Medicine Market Size (US$ Mn) Forecast, 2016-2024
  • Figure 79: Rest of LATAM Precision Medicine Market, Absolute $ Opportunity (US$ Mn), 2016-2024
  • Figure 80: Latin America Precision Medicine Market Attractiveness Analysis: by Technology, 2016-2024
  • Figure 81: Latin America Precision Medicine Market Attractiveness Analysis: by Application, 2016-2024
  • Figure 82: MEA Precision Medicine Market Size (US$ Mn) and Volume (Units) Forecast, 2016-2024
  • Figure 83: MEA Precision Medicine Market Size and Y-o-Y Growth Projections, 2016-2024
  • Figure 84: MEA Precision Medicine Market Attractiveness Analysis, by Country
  • Figure 85: Middle East & Africa Precision Medicine Market Value Share Analysis: by Technology, 2016 and 2024
  • Figure 86: Middle East & Africa Precision Medicine Market Value Share Analysis: by Application, 2016 and 2024
  • Figure 87: MEA Precision Medicine Market Value Share Analysis: by Country, 2016 and 2024
  • Figure 88: Saudi Arabia Precision Medicine Market Size (US$ Mn) Forecast, 2016-2024
  • Figure 89: Saudi Arabia Precision Medicine Market, Absolute $ Opportunity (US$ Mn), 2016-2024
  • Figure 90: UAE Precision Medicine Market Size (US$ Mn) Forecast, 2016-2024
  • Figure 91: UAE Precision Medicine Market, Absolute $ Opportunity (US$ Mn), 2016-2024
  • Figure 92: RSA Precision Medicine Market Size (US$ Mn) Forecast, 2016-2024
  • Figure 93: RSA Precision Medicine Market, Absolute $ Opportunity (US$ Mn), 2016-2024
  • Figure 94: Rest of MEA Precision Medicine Market Size (US$ Mn) Forecast, 2016-2024
  • Figure 95: Rest of MEA Precision Medicine Market, Absolute $ Opportunity (US$ Mn), 2016-2024
  • Figure 96: MEA Precision Medicine Market Attractiveness Analysis, by Technology, 2016-2024
  • Figure 97: MEA Precision Medicine Market Attractiveness Analysis, by Application, 2016-2024
Back to Top